Literature DB >> 3408021

Cardiac alterations in ankylosing spondylitis.

M G Alves1, J Espirito-Santo, M V Queiroz, H Madeira, E Macieira-Coelho.   

Abstract

Forty patients, 30 men and 10 women with an average age of 38.47 +/- 11.07 years, suffering from ankylosing spondylitis and attending a Rheumatology Outpatient Clinic, were evaluated for cardiovascular involvement. The evaluation was based on patients' clinical observation, electrocardiography, echocardiography, and chest x-ray. More than a simple review, this study was undertaken with the aim of arriving at a better clinical definition of the cardiovascular manifestations found in ankylosing spondylitis. In fact, of the 40 patients, 8 (20%) had systemic hypertension for which an explanation could not be found, 4 of whom were less than forty-five years old; the echocardiogram showed mitral valve prolapse in 4 patients (10%), 2 of them with a systolic murmur and other 2 with a protosystolic click on auscultation. More significant than the changes in conduction was the finding of a sinus bradycardia in 9 patients (22.5%), and a PR interval below 120 msec in 3 patients (7.5%). The authors conclude that the extension of cardiovascular changes in ankylosing spondylitis is more vast than usually acknowledged.

Entities:  

Mesh:

Year:  1988        PMID: 3408021     DOI: 10.1177/000331978803900702

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  8 in total

Review 1.  Ankylosing spondylitis: A state of the art factual backbone.

Authors:  Mohammad Ghasemi-Rad; Hosam Attaya; Emal Lesha; Andrea Vegh; Tooraj Maleki-Miandoab; Emad Nosair; Nariman Sepehrvand; Ali Davarian; Hamid Rajebi; Abdolghader Pakniat; Seyed Amirhossein Fazeli; Afshin Mohammadi
Journal:  World J Radiol       Date:  2015-09-28

Review 2.  The heart in ankylosing spondylitis.

Authors:  T W O'Neill; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1992-06       Impact factor: 19.103

3.  High prevalence of metabolic syndrome in patients with ankylosing spondylitis.

Authors:  Domenico Malesci; Alferio Niglio; Gianna Angela Mennillo; Rosario Buono; Gabriele Valentini; Giovanni La Montagna
Journal:  Clin Rheumatol       Date:  2006-08-25       Impact factor: 2.980

4.  Coexistence of spinal arteriovenous malformation and ankylosing spondylitis--are they related?

Authors:  J Y Chen; H H Ho; Y J Wu; S F Luo
Journal:  Clin Rheumatol       Date:  1994-09       Impact factor: 2.980

5.  Echocardiographic abnormalities in ankylosing spondylitis.

Authors:  T W O'Neill; G King; I M Graham; J Molony; B Bresnihan
Journal:  Ann Rheum Dis       Date:  1992-05       Impact factor: 19.103

6.  Anti-TNF Therapy in Ankylosing Spondylitis: Insights for the Clinician.

Authors:  Laura C Coates; Helena Marzo-Ortega; Alexander N Bennett; Paul Emery
Journal:  Ther Adv Musculoskelet Dis       Date:  2010-02       Impact factor: 5.346

Review 7.  Cardiac Involvement in Ankylosing Spondylitis.

Authors:  Yasemin Ozkan
Journal:  J Clin Med Res       Date:  2016-05-25

8.  Lifetime Risks of Valvular Heart Disease and Pacemaker Use in Patients With Ankylosing Spondylitis.

Authors:  Michael M Ward
Journal:  J Am Heart Assoc       Date:  2018-10-16       Impact factor: 5.501

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.